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Abstract
Many enveloped viruses complete their replication cycle by forming vesicles that bud from the plasma membrane. Some viruses encode “late”
(L) domain motifs that are able to hijack host proteins involved in the vacuolar protein sorting (VPS) pathway, a cellular budding process that
gives rise to multivesicular bodies and that is topologically equivalent to virus budding. Although many enveloped viruses share this mechanism,
examples of viruses that require additional viral factors and viruses that appear to be independent of the VPS pathway have been identified.
Alternative mechanisms for virus budding could involve other topologically similar process such as cell abscission, which occurs following
cytokinesis, or virus budding could proceed spontaneously as a result of lipid microdomain accumulation of viral proteins. Further examination of
novel virus–host protein interactions and characterization of other enveloped viruses for which budding requirements are currently unknown will
lead to a better understanding of the cellular processes involved in virus assembly and budding.
© 2007 Elsevier Inc. All rights reserved.Keywords: Virus budding; Enveloped virus assembly; Virus exit; Late domain; ESCRT pathwayIntroduction
The mechanism by which enveloped viruses complete their
replication cycle by budding through a cellular membrane
presents a biophysical problem. After a complex, multistep
process involving the proper transport and organization of viral
proteins on the membrane, followed by incorporation of the
genetic material, enveloped viruses must then form viral par-
ticles by deforming the membrane and, finally, pinching off
from the membrane in a membrane fission step. Much as
enveloped viruses entering a cell have to do so by mediating
fusion of their membrane with a cellular membrane, viruses
exiting a cell encounter the problem of membrane fission to
release the nascent particles from the host membrane. To faci-
litate fusion, many enveloped viruses have encoded fusion
machines in the form of fusion proteins present on the viral⁎ Corresponding author. Department of Biochemistry, Molecular Biology and
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doi:10.1016/j.virol.2007.11.008surface. These fusion proteins undergo dramatic conformational
changes, converting the free energy released by refolding of the
fusion protein into energy that is used to merge together viral
and cellular membranes. However, for budding, no such virus-
encoded protein is known to exist to overcome the energy
barrier required for membrane fission.
As budding is an essential step in the life cycle of enveloped
viruses, the mechanisms employed by viruses to accomplish
this task have been an area of intense recent study. Whereas
these mechanisms have previously been categorized under the
rubric of “push vs. pull” processes (Garoff et al., 1998; Welsch
et al., 2007), it is likely that a continuum or combination of
forces is employed by viruses to induce membrane vesicular-
ization and fission.
Host-assisted budding
The concept that viruses might utilize a cellular process to
assist in virus budding arose initially from observations of
retroviruses that failed to be released from cells during the late
stages of virus budding. For human immunodeficiency virus
Table 1
Enveloped viruses that possess L domains that interact with cellular proteins in the VPS pathway
Virus Viral protein:
L domain a
Direct interactions b References c
Retroviruses
Human immunodeficiency virus-1 Gag (p6): Göttlinger et al. (1991)
PTAP Tsg101 Huang et al. (1995)
YPDL AIP1/Alix Garrus et al. (2001)
(ESCRT I, III) Martin-Serrano et al. (2001)
(Vps4A/B) Martin-Serrano et al. (2003b)
Strack et al. (2003)
Martin-Serrano et al. (2003a)
von Schwedler et al. (2003)
Stuchell et al. (2004)
Rous sarcoma virus Gag (p2b): Wills et al. (1994)
PPPPYV Nedd4 Xiang et al. (1996)
(Vps4A) Kikonyogo et al. (2001)
Vana et al. (2004)
Medina et al. (2005)
Equine infectious anemia virus Gag (p9): Puffer et al. (1997)
YPDL AIP1/Alix Puffer et al. (1998)
AP-2 Li et al. (2002)
Strack et al. (2003)
Martin-Serrano et al. (2003a)
Shehu-Xhilaga et al. (2004)
Chen et al. (2005b)
Mason-Pfizer monkey virus Gag (p24): Yasuda and Hunter (1998)
PSAP Tsg101 Gottwein et al. (2003)
PPPY Nedd4
(Vps4A)
Moloney murine leukemia virus Gag (MA, p12): Yuan et al. (1999)
PSAP Tsg101 Segura-Morales et al. (2005)
PPPY AIP1/Alix
(Nedd4)
Human T cell leukemia virus-1 Gag (MA): Le Blanc et al. (2002)
PPPY Nedd4.1 Bouamr et al. (2003)
WWP1 Wang et al. (2004)
(PTAP) Tsg101 Blot et al. (2004)
(Vps4A/B) Heidecker et al. (2004)
(AIP1/Alix) Dorweiler et al. (2006)
Urata et al. (2007b)
Heidecker et al. (2007)
Prototypic foamy virus Gag: Stange et al. (2005)
PSAP Tsg101 Patton et al. (2005)
(PPPI)
(YEIL)
(Vps4A/4B)
(CHMP3)
Rhabdoviruses
Vesicular stomatitis virus M: Harty et al. (1999)
PPPY Nedd4 Craven et al. (1999)
(PSAP) Jayakar et al. (2000)
Irie et al. (2004b)
Irie et al. (2004a)
Irie and Harty (2005)
Rabies virus M: PPEY Nedd4 Harty et al. (1999)
Filoviruses
Ebola virus VP40: Harty et al. (2000)
PTAPPEY Tsg101 Martin-Serrano et al. (2001)
Nedd4 Licata et al. (2003)
Timmins et al. (2003)
Yasuda et al. (2003)
Irie et al. (2005)
222 Minireview
Virus Viral protein:
L domain a
Direct interactions b References c
Marburg virus VP40: Kolesnikova et al. (2004)
PPEY Tsg101 Urata et al. (2007a)
Arenaviruses
Lymphocytic choriomeningitis virus Z: Perez et al. (2003)
PTAP Tsg101
PPPY
Lassa virus Z: Perez et al. (2003)
PTAP Tsg101 Urata et al. (2006)
PPPY
(Vps4A)
Paramyxoviruses
Parainfluenza virus-5 M: Schmitt et al. (2005)
FPIV n.d.
(Vps4A)
Nipah virus M: Ciancanelli and Basler (2006)
YMYL n.d.
Sendai virus C: ? AIP1/Alix d Sakaguchi et al. (2005)
M: YLDL AIP1/Alix d Irie et al. (2007)
(Vps4A) d Gosselin-Grenet et al. (2007)
Other RNA viruses
Japanese encephalitis virus NS3 Tsg101 Chiou et al. (2003)
Bluetongue virus NS3/3A: Wirblich et al. (2006)
PSAP Tsg101
(PPRY) Nedd4
DNA viruses
Hepatitis B virus (Vps4A/4B) Kian Chua et al. (2006)
(ESCRT-III) Watanabe et al. (2007)
(AIP1/Alix)
(Nedd4) Lambert et al. (2007)
Vaccinia virus F13L: YPPL n.d. Honeychurch et al. (2007)
Herpes simplex virus-1 (Vps4) Crump et al. (2007)
Calistri et al. (2007)
Epstein–Barr virus Rta Tsg101 e Chua et al. (2007)
n.d. — Not determined.
a L domains in parentheses represent secondary domains that contribute subtly to budding.
b Direct interactions as determined by yeast two-hybrid, coimmunoprecipitation, or colocalization studies. Proteins in parentheses indicate functional importance in
budding as determined by dominant-negative or cellular depletion studies.
c References are listed in chronological order.
d Conflicting reports.
e EBV requires Tsg101 for late gene transcription only.
Table 1 (continued )
223Minireviewtype-1 (HIV-1), disruption of the p6 region of Gag resulted in
defective virus budding, characterized by vesicles that appeared
to be fully formed but remained tethered to the plasma mem-
brane (Göttlinger et al., 1991). Analysis of the p6 region revealed
a PTAP amino acid motif, mutation of which was responsible for
this defect in HIV-1 budding (Göttlinger et al., 1991; Huang
et al., 1995). A similar analysis of the p2b region of Rous
sarcoma virus Gag identified a PPPY motif (Wills et al., 1994).
For the filovirus Ebola virus, overlapping motifs (PTAPPPEY)
in the VP40 structural protein were each found to contribute to
efficient budding of subviral particles (Harty et al., 2000; Licata
et al., 2003; Martin-Serrano et al., 2001). These motifs along
with other motifs characterized subsequently, including YPxL
and FPIV, have been identified in a variety of viruses (Table 1)
and termed late (L) domains. Disruption of these domains typi-
cally results in defects during the late stages of budding, particu-larly at the final step of vesicle fission (reviewed in Bieniasz,
2006; Morita and Sundquist, 2004; Schmitt and Lamb, 2004).
The feature that makes the existence of L domains in the
proteins of a variety of enveloped viruses so compelling is that
these motifs have now been demonstrated, by biochemical and
structural studies, to interact with cellular proteins. Under nor-
mal circumstances, these cellular proteins are involved in
pathways that promote the formation of vesicles that bud away
from the cytoplasm, a process analogous to virus budding and
distinct from inward budding processes such as endocytosis
(Fig. 1). The most studied of these pathways is the vacuolar
protein sorting (VPS) pathway, a branch of which gives rise to
multivesicular bodies (MVB) (Fig. 1A). Another topologically
equivalent cellular process includes abscission during cytokin-
esis, which utilizes an overlapping subset of cellular proteins
(discussed below, Fig. 1C).
Fig. 1. Vesicularization pathways. (A) Cellular VPS pathway and MVB biogenesis. Receptors on the plasma membrane destined for degradation are internalized into
vesicles by endocytosis which fuse with other vesicles to form endosomes en route to the lysosome. Ubiquitination of cargo proteins recruits the ESCRTcomplexes. To
formMVBs, Vps4 AAA-ATPase activity is required to remove ESCRT-III proteins from the membrane and induce vesicularization. (B) Enveloped virus budding from
the plasma membrane. For some enveloped viruses, viral proteins recruit components of the ESCRT complex through L domains, redirecting the MVB formation
machinery from endosomes to sites of virus budding. (C) Abscission. To complete cytokinesis, abscission requires the recruitment of ESCRT proteins Tsg101 and
AIP1/Alix by Cep55 to the midbody, and the activity of Vps4. The membrane topology of abscission, when the daughter cell pinches off, is equivalent to both MVB
formation and virus budding.
224 MinireviewMVB vesicles are formed on late endosomes and contain
cargo destined for lysosomal degradation. MVB formation re-
quires the activity of a network of cytoplasmic protein com-
plexes, known as ESCRT (endosomal sorting complex required
for transport) complexes I, II, and III, that are sequentially, or
perhaps concentrically, recruited to the endosomal membrane to
sequester cargo proteins and drive vesicularization into the
endosome (reviewed in Hurley and Emr, 2006; Nickerson et al.,
2007) (Fig. 2). Proteins comprising the ESCRT I, II, and III
intracellular trafficking machinery are evolutionarily conserved
from yeast to humans. The atomic structure of two key com-
ponents of this pathway – Tsg101, a component of ESCRT-I,
and AIP1/Alix, a protein that bridges the interaction between
ESCRT-I and ESCRT-III – revealed the binding pockets for the
L domain motifs P(T/S)AP and YPxL, respectively (Fisher
et al., 2007; Lee et al., 2007; Pornillos et al., 2002). These
interactions between viral proteins and ESCRT proteins are
thought to redirect the ESCRT machinery to the site of virus
budding where viral particle vesicularization is required, and
they are thought to constitute a “pushing” force for virus bud-
ding (Figs. 1B and 2). A third L domain motif, PPxY, is able to
bind the protein Nedd4 and similar HECT domain-containing
E3 ubiquitin ligases, proteins which presumably feed into theVPS pathway upstream of the ESCRT complexes (Martin-
Serrano et al., 2005) (Fig 2).
The final step of budding when vesicles pinch off from the
membrane is perhaps the least well understood. A key protein,
however, appears to be the AAA-ATPase Vps4, which is
present in humans as two isoforms, Vps4A and Vps4B (Babst
et al., 1998; Scheuring et al., 2001). Based on structural and
functional studies, Vps4 is thought to remove catalytically the
ESCRT-III complex from the endosomal membrane resulting
in the contraction of the membrane surrounding the nascent
vesicle, leading to membrane fission (Scott et al., 2005a,b).
This activity is required for MVB formation because
dominant-negative forms of Vps4, in which the ATPase
catalytic site is ablated by mutation, induce a phenotype in
which incomplete and aberrantly formed vesicles accumulate
and fail to separate from the membrane (Fujita et al., 2003;
Scheuring et al., 2001).
The list of viruses that have been shown to utilize the VPS
pathway and ESCRT proteins during budding is now quite
extensive (Table 1). Our understanding of the proteins that make up
the complexes involved in MVB biogenesis is also expanding as
new components are identified (reviewed inHurley and Emr, 2006;
Williams andUrbé, 2007). As different viruses are shown to require
225Minireviewcomponents of this vesicularization pathway, the importance of this
mechanism to virus budding becomes satisfyingly reinforced.
However, this mechanism does not appear to apply uni-
versally to, nor is it sufficient for, budding of all enveloped
viruses. Notable exceptions have gradually accumulated in the
literature that suggest that requirements for enveloped virus
budding can be more complex than simply redirecting the
ESCRT components. In some cases, recruitment of ESCRT
factors may not be sufficient for budding. In other cases, budding
appears to be entirely independent of known cellular pathways.
The VPS pathway is required but not sufficient for some
viruses
Virus-like particle (VLP) systems and reverse genetics have
become important tools with which to dissect the budding
requirements for a number of enveloped viruses. Internal struc-
tural proteins of enveloped viruses are attractive candidates for
organizing virus budding as they are often thought to form
bridging interactions between the viral envelope proteins and
genome-containing core. Whereas many L domain-containingFig. 2. ESCRT complexes and vesicle formation. ESCRT complexes I, II, and III are
complex interactions. The AAA-ATPase Vps4A/B facilitates MVB vesicle formation
found in viral proteins interact with components of the VPS pathway, redirecting thstructural proteins are able to drive budding and thus are
believed to contain sufficient information to direct budding
independently of other viral proteins, there are several enveloped
viruses that, although they appear to encode L domains and
require VPS components, they also require additional viral
proteins for budding.
Among the retroviruses, foamy virus budding is different in
that Env is essential for particle formation in addition to Gag
(Fischer et al., 1998; Shaw et al., 2003).Whereas the Gag proteins
of all other retroviruses tested thus far are able to formVLPswhen
expressed alone, prototype foamy virus (PFV) Gag is unable to
form VLPs. Despite this observation, analysis of the PFV Gag
protein revealed a dominant PSAP L domain similar to that of
other retrovirus Gag proteins. Furthermore, budding of viral
particles was sensitive to dominant-negative mutants of Tsg101,
CHMP-3, and Vps4 (Patton et al., 2005; Stange et al., 2005).
Similar to PFV, the matrix (M) protein of the paramyxovirus
parainfluenza virus 5 (PIV5) also contains an L domain (Schmitt
et al., 2005), yet expression of the M protein alone in cells does
not result in vesicle formation (Schmitt et al., 2002). In VLP
studies, theM protein is only released efficiently into VLPs uponrecruited to the endosomal membrane by ubiquitinated cargo proteins and inter-
by removing ESCRT-III subunits from the endosomal surface. Viral L domains
e complexes to the site of virus budding on the plasma membrane.
226 Minireviewcoexpression of the nucleocapsid protein (NP) and the spike
glycoproteins (F or HN). Furthermore, the cytoplasmic tails of F
orHNwere shown to be required forVLP budding aswell as virus
replication, suggesting a role for these proteins in directing proper
assembly of the virion prior to budding (Schmitt et al., 2002).
Indeed, truncation of the cytoplasmic tails of F or HN resulted in a
diffuse redistribution of M within cells infected with recombinant
mutant viruses (Schmitt et al., 1999; Waning et al., 2002).
In the case of both PFV and PIV5, there appears to be a
requirement for proper assembly of viral components prior to
budding. This function appears to be supplied by the inte-
gral membrane proteins of the viral envelope. For PFV, it has
been shown that targeting of Gag, which lacks an N-terminal
myristylation signal usually found on retroviral Gag proteins, to
the membrane requires Env, and that this targeting is specific as
budding is only observed in the presence of homologous Env
proteins (Eastman and Linial, 2001; Pietschmann et al., 1999).
For PIV5, the recruitment of M by F and HN may be crucial for
proper assembly prior to budding.
Compared to the budding of other enveloped viruses, the
failure of PFV and PIV5 structural proteins to bud indepen-
dently may represent differences in assembly efficiency. Clear-
ly, it is advantageous to bud only after proper assembly has
occurred. Thus, a limiting step to virus budding may be the
recruitment of internal viral proteins by the surface membrane
proteins to sites of virus budding. Targeting of the internal
components to the surface may then redirect the budding
machinery bound to L domains, leading to particle formation.
At least two virus families have envelope proteins, rather than
internal proteins, that encode L-domain-like motifs in their
cytoplasmic domains. Budding of the orbivirus bluetongue virus
requires the transmembrane proteins NS3 and NS3A for VLP
budding (Hyatt et al., 1993). NS3/NS3A contains a dominant
PSAP L domain motif in its N-terminal cytoplasmic domain that
can complement budding-deficient Gag constructs, and budding
of VLPs and virus was reduced when Tsg101 was depleted by
using RNAi techniques (Wirblich et al., 2006). Within the
vaccinia virus F13L envelope protein cytoplasmic tail, a YPPL L
domain motif, conserved in many poxviruses, has been described
(Honeychurch et al., 2007).Amodest decrease in virus replication
was observed when this motif was mutated and when AIP1/Alix
was depleted from cells, suggesting the use of VPS proteins in the
envelopment of this large DNA virus.
VPS pathway-independent virus budding
For some enveloped viruses, there is evidence that budding can
occur independent of an active VPS pathway. This category of
enveloped viruses is characterized by the ability to bud and
replicate in the presence of dominant-negative forms of Vps4. As
Vps4 is believed to function at the final steps of MVB biogenesis
and is required for the final pinching off ofMVBs, the finding that
several viruses do not require its function suggest either the
presence of alternative vesicularization pathways or complete
independence of virus budding from cellular assistance.
The budding requirements of vesicular stomatitis virus
(VSV) have been examined extensively and VSV was one ofthe first non-retrovirus examples of a virus containing a putative
L domain motif (Craven et al., 1999; Harty et al., 1999).
Although the M protein of VSV contains both PPPY and PSAP
motifs, it has been shown that only the PPPY motif is required
for efficient virus replication (Irie et al., 2004a; Jayakar et al.,
2000). Thus, it was not entirely surprising that VSV VLP bud-
ding was not inhibited by Tsg101 depletion; however, the ability
of VSV VLPs and infectious virions to bud in the presence of
dominant-negative Vps4A was unexpected (Irie et al., 2004b).
The VSV M protein has been shown to interact with the
ubiquitin ligase Nedd4 in a PPPY-dependent manner suggesting
an alternative pathway linking cellular machinery to VSV
budding, possibly through ubiquitination (Harty et al., 2001,
1999). Other viruses with PPPYmotifs that interact with Nedd4-
like proteins, however, do require Vps4A activity (Table 1)
highlighting the unusual nature of VSV budding.
Studies examining the requirements for Sendai virus bud-
ding have yielded conflicting data. Initially, it was reported that
coexpression of both M and F proteins was required for Sendai
VLP budding suggesting that both proteins were required to
drive budding (Takimoto et al., 2001). However, additional
studies found that the nonstructural C protein enhanced VLP
release (Sugahara et al., 2004). One explanation for the
enhanced budding contributed by the C protein is that the C
protein can bind AIP1/Alix, despite lacking a YPxL motif
(Sakaguchi et al., 2005). This finding was somewhat surprising
in that it was the first example of a nonstructural protein po-
tentially linking virus budding to the ESCRT pathway. Later
studies, however, identified a YLDL motif in the Sendai virus
M protein and it was shown that this motif could also interact
with AIP1/Alix (Irie et al., 2007). The YLDL motif was shown
to be essential for VLP budding independent of the C protein,
consistent with the mechanism used by other enveloped viruses
that utilize the ESCRT pathway. However, a recent study sug-
gests that Sendai virus budding in the context of a biological
infection, rather than a VLP context, is not sensitive to AIP1/
Alix depletion or dominant-negative Vps4 (Gosselin-Grenet
et al., 2007). Currently, it is difficult to reconcile the discre-
pancies between the conflicting studies, although it is apparent
that there may be differences in ESCRT utilization between
VLP systems and biological infections, perhaps due to over-
expression from transfected plasmids. For Ebola virus, a mutant
virus was recovered containing an altered VP40 L domain and it
was found that only a small decrease in replication occurred
(Neumann et al., 2005). This raises the question of whether
cellular assistance simply enhances budding efficiency. Why
the requirement for the VPS pathway differs among viruses
during an actual virus infection as compared to the effects
observed with VLP systems is a topic worthy of additional
investigation.
For influenza virus, there have also been discrepancies
among different studies of the requirements for budding. Simi-
lar to findings with other enveloped viruses, early influenza
VLP studies suggested that the matrix protein (M1) served as
the major driving force for virus budding (Gómez-Puertas et al.,
2000). This conclusion was consistent with the notion that
internal viral structural proteins are sufficient to drive virus
227Minireviewbudding due to the recruitment of cellular factors, similar to the
example of the retroviruses and filoviruses.
In contrast to previous reports, it was found recently that if a
noncytotoxic VLP system that reflects a biological infection is
used, M1 expressed on its own does not produce VLPs and is
not required for VLP formation (Chen et al., 2007). The major
requirement for VLP budding was found to be the hemagglu-
tinin (HA) protein, in particular the cytoplasmic tail of HA.
Numerous studies have examined the contribution of the HA
and neuraminidase (NA) cytoplasmic domains to influenza
virus assembly and budding (Jin et al., 1997; Zhang et al.,
2000a,b). These studies suggest the that HA and NA tails are
functionally redundant and that the secondary structure or
orientation of the cytoplasmic domains could be important for
proper assembly of the virus, as removal of an essential proline
residue in the NA tail (Bilsel et al., 1993) or the palmitoylation
sites in the HA tail (Chen et al., 2005a) affect the viability of
recombinant viruses and affect M1 incorporation into the virion.
Taken together, these studies suggest that the envelope
glycoproteins HA and NA serve to direct assembly and are
required for virus budding. Indeed, VLPs failed to bud in the
absence of HA, but VLPs without M1 resembled authentic
influenza virions (Chen et al., 2007) (Fig. 3). Furthermore,
budding of influenza VLPs was not sensitive to dominant-
negative Vps4 in contrast to budding of HIV-1 and PIV5, but
similar to the findings with VSV budding (Chen et al., 2007)
(Fig. 4).Fig. 3. Influenza VLP morphology as shown by EM. Influenza virions, VLPs contain
prepared by infecting or transfecting 293T cells. Purified virions and VLPs were imm
15-nm gold and then negative stained. Scale bar, 100 nm. From Chen et al. (2007)Placed in the context of other enveloped viruses that have been
examined to date, it appears that influenza virus budding is
different in that it does not require the AAA-ATPase activity of
Vps4 and it does not contain a known L domain motif. The
importance of the cytoplasmic tails of the viral membrane proteins
suggests a functional role for these proteins in the assembly of the
virus, similar to findings with PIV5 and PFV assembly and
budding. The organizing role played by the influenza virus mem-
brane proteins is also reminiscent of alphavirus assembly where
the interaction between the spike glycoprotein E2 and nucleo-
capsid is required for organization of an icosahedral capsid
(Forsell et al., 2000; Lopez et al., 1994; Suomalainen et al., 1992).
Thus, if budding of some viruses does not require the AAA-
ATPase activity of Vps4, are there alternative cellular pathways
that lead to vesicle formation that are Vps4-independent? Do
these pathways also use ESCRT complexes, or are there com-
pletely novel vesicularization pathways in the cell? For both VSV
and Sendai virus, budding appears to be independent of the VPS
pathway despite containing L-domain-like motifs. This raises the
possibility that there are multiple entry and exit points within the
VPS network and possibly cross talk with other cellular networks
where Vps4 activity is not a required component.
Certainly, a trend has emerged where enveloped virus bud-
ding in the presence of dominant-negative Vps4 is treated as a
gold standard test applied to numerous enveloped viruses to
determine whether budding occurs through the VPS pathway.
Budding of a number of enveloped viruses has now been showning all VLP proteins (WT VLP), and VLPs lacking M1 protein (M1- VLP) were
unostained with a monoclonal anti-HA antibody followed by IgG conjugated to
with permission from the American Society for Microbiology.
Fig. 4. Budding of HIV-1, influenza VLPs, PIV5 VLPs, and VSV in the presence of dominant-negative Vps4. Budding of HIV-1 in the presence of dominant-negative
Vps4A-KQ or Vps4B-KQ (A), or budding of influenza VLPs (B), PIV5 VLPs (C), or VSV (D) in the presence of increasing amounts of dominant-negative Vps4A-EQ
was tested. HIV-1 and PIV5 VLP budding was dramatically reduced whereas VSVand influenza VLP budding was not inhibited. Adapted from Chen et al. (2007) with
permission from the American Society for Microbiology.
228 Minireviewto be sensitive to dominant-negative Vps4, including viruses
such as hepatitis B virus (Kian Chua et al., 2006; Lambert et al.,
2007;Watanabe et al., 2007) and herpes simplex virus-1 (Calistri
et al., 2007; Crump et al., 2007) (Table 1). As more viruses are
categorized in this manner, it will be interesting to determine
whether these viruses contain conventional or novel L domains
and whether they interact with known ESCRT components.
Greater advances will be made, however, by identifying viruses
that are insensitive to dominant-negative Vps4, and by
uncovering pathways that diverge from the currently under-
stood cellular pathways by identifying novel viral–cellular pro-
tein interactions.
Besides the well-studied MVB pathway, one mechanism
related topologically to MVB formation and virus budding is
the final step of cytokinesis, known as abscission, during which
two daughter cells separate (Fig. 1C). A recent study found that
both Tsg101 and AIP1/Alix are recruited to sites of abscission
by Cep55, a centrosome protein required for abscission (Carlton
and Martin-Serrano, 2007). Depletion of either Tsg101 or AIP1/
Alix increased the number of cells arrested during cell division,
suggesting the ESCRT complexes are involved in this related
membrane fission event (Carlton and Martin-Serrano, 2007).
Cytokinesis was also sensitive to dominant-negative Vps4 and
other components of the VPS pathway. Although the processes
of MVB formation and abscission are related through common
cellular machinery, there are also unique elements. For example
syntaxin-2 and vamp-8 were both required for cell division but
dominant-negative forms of each did not inhibit HIV-1 budding
(Carlton and Martin-Serrano, 2007). Also, although Cep55
overexpression inhibited both cytokinesis and HIV-1 budding,
Cep55 itself was not required for virus budding as a Tsg101
mutant that could not bind to Cep55 was still able to rescue
HIV-1 budding (Carlton and Martin-Serrano, 2007). This raisesthe intriguing possibility that the cell is able to relocate the
ESCRT machinery through the use of adapter proteins to var-
ious locations within the cell to participate in different budding
events. It will be interesting to investigate whether viruses are
able to recruit similar adapter proteins as a means of com-
mandeering the VPS pathway for their own use.
Intrinsic budding potential
Although hijacking the cellular machinery used in MVB
biogenesis or cytokinesis for virus budding is an attractive and
satisfying mechanism for virus budding, there is evidence that
suggests that virus budding can also proceed spontaneously
without the help of host factors.
Budding of viruses such as alphaviruses, PIV5, and in-
fluenza virus appears to be driven by integral membrane pro-
teins as discussed above. Although host proteins may still be
involved with budding of these viruses, the intrinsic association
of viral proteins into microdomains on the plasma membrane
may be sufficient to drive virus budding by inducing membrane
curvature and supplying a “pulling” force for virus formation.
The lipid raft association of many enveloped viruses, such as
HIV-1 (Lindwasser and Resh, 2001; Ono and Freed, 2001),
Ebola virus (Bavari et al., 2002), VSV (Brown and Lyles,
2003), and influenza virus (Scheiffele et al., 1999), has sug-
gested that these microdomains serve as virus “budozones”
where viral proteins are concentrated to facilitate efficient virus
budding (reviewed in Schmitt and Lamb, 2004, 2005). For
influenza virus, lipid raft association is an intrinsic property of
HA (Leser and Lamb, 2005), and HA raft association is required
for efficient virus replication (Takeda et al., 2003). Combined
with evidence that the HA and NA cytoplasmic tails (Ali et al.,
2000; Enami and Enami, 1996; Zhang et al., 2000a,b), along
229Minireviewwith the M2 cytoplasmic tail (McCown and Pekosz, 2005),
recruit M1 and contribute to packaging of the viral RNA-
containing ribonucleoprotein complex, lipid microdomain
association may play an additional role in budding by
promoting the clustering of a critical mass of viral proteins to
nucleate membrane vesicularization independent of host
budding machinery.
Recent computer simulations have shown quite dramatically
that spontaneous membrane vesicularization can occur in
environments analogous to that of viral budozones (Reynwar
et al., 2007). In these simulations, when small proteins were
placed in a simulated lipid environment, similar in scale to lipid
microdomains (160×160 nm), vesicular structures formed
spontaneously despite a lack of inter-protein interactions. Ra-
ther, the vesicularization was induced by local hydrophilic
attraction between the proteins and their immediate lipid
environment. These local attractions led to aggregation and
local membrane curvature which summed over the membrane to
induce vesicle formation. Additionally, when virus capsid-sized
particles were placed in the lipid environment, these also in-
duced spontaneous vesicle formation (Reynwar et al., 2007)
(Fig. 5).
Thus, in the case of influenza virus, it is possible that the
accumulation of viral proteins into lipid raft microdomains is
sufficient to induce vesicle formation due to attractive forces
between the viral proteins and the plasma membrane. This
mechanism may serve as a default process for other lipid
microdomain-associated viruses as well. In vitro analysis of
VSV M protein has demonstrated that the M protein alone,
reconstituted in artificial liposomes, can induce membrane
curvature reminiscent of virus budding (Solon et al., 2005).
However, complete, budded vesicles were not observed in thisFig. 5. Computer simulation of spontaneous membrane vesicularization. In coarse-gra
in the simulated lipid environment drove vesicle budding through attractive and coo
course of approximately 0.3 ms. Adapted from Reynwar et al. (2007) with permissisystem (Solon et al., 2005) nor in computer simulations
(Reynwar et al., 2007), suggesting that host factors may still
be required for the final pinching off step.
Perspectives
The biophysical problem posed by virus budding may
therefore not be as difficult as it seems. What is intriguing is
how different viruses accomplish this task in seemingly
disparate ways. How is assembly that is organized by the
integral membrane proteins on the cell surface translated into
efficient virus budding? Is there a balance between micro-
domain association (pulling forces) and host protein recruitment
(pushing forces)? Do differing requirements for budding reflect
fundamentally different mechanisms for virus budding; or, do
they illustrate spatial and temporal restrictions or targeting
strategies unique to different viruses that ultimately feed into a
similar vesicularization pathway? Does the structure of a given
virus increase or decrease the amount of assistance required to
form a viral particle? Dissecting the relative contributions of
lateral membrane protein interactions, interactions between in-
ternal and membrane proteins, and “pushing” forces from re-
cruited internal proteins to virus budding will increase our
understanding of how different viruses escape from the cell.
Furthermore, determining the consequences of interactions bet-
ween viral proteins and cellular budding machinery on phy-
siologic processes may reveal an additional mechanism by which
viruses disable the host cell.
As the budding requirements of more enveloped viruses are
cataloged, the network of cellular proteins involved in this
process will likely expand and perhaps lead to the identification
of novel cellular pathways. The membrane fission step remainsined computer simulations modeling membrane vesicularization, capsids placed
perative forces. Panels A–F show a series of simulation snapshots over a time
on from the Nature Publishing Group.
230 Minireviewthe least well understood, both for virus budding and cellular
budding. The identity, recruitment, and mechanism of action of
host factors involved in fission should be a priority, much as the
in-depth examination of viral fusion proteins and cellular
SNARE proteins helped definemembrane fusion. Technological
advancements in mass spectrometry and large-scale proteome
mapping will be crucial to finding new and pertinent interactions
between viral and cellular proteins. Visualization of virus
budding by using real time high-resolution single-particle light
microscopy and by using cryoelectron tomography and
correlative electron microscopy techniques may shed light on
this process as well.
Gaining a better understanding of virus budding and ap-
preciating the diversity of strategies employed by different viruses
will not only lead to a better understanding of fundamental
cellular processes but also has the potential to lead to alternative
therapeutic approaches to treating enveloped virus infections.
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